| For: | Pasarín M, Abraldes JG, Liguori E, Kok B, La Mura V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. World J Gastroenterol 2017; 23(37): 6777-6787 [PMID: 29085222 DOI: 10.3748/wjg.v23.i37.6777] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i37/6777.htm |
| Number | Citing Articles |
| 1 |
A A Shipovskaya, O P Dudanova, I V Kurbatova. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2018; 90(8) doi: 10.26442/terarkh201890863-68
|
| 2 |
Taraneh Faghihi Langroudi, Habib Haybar, Saeed Alipour Parsa, Mohamad Mahjoorian, Isa Khaheshi, Mohammadreza Naderian. The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography. Romanian Journal of Internal Medicine 2018; 56(3) doi: 10.2478/rjim-2018-0009
|
| 3 |
Carlos Rojano-Alfonso, Cristina López-Vicario, Berta Romero-Grimaldo, Bryan J. Contreras, Joan Clària, Esther Titos. Hyaluronic Acid in Liver Fibrosis: Role in Inflammation, Tissue Remodeling, and Disease Progression. International Journal of Molecular Sciences 2025; 26(20) doi: 10.3390/ijms262010139
|
| 4 |
P. V. Koroy, Yu. A. Kravchenko, A. V. Yagoda. The possibilities of soluble selectins in the prediction of severe fi brosis in nonalcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2022; (3) doi: 10.31146/1682-8658-ecg-199-3-50-56
|
| 5 |
Yan Lv, Nishant Patel, Hai-Jun Zhang. The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer. Expert Review of Gastroenterology & Hepatology 2019; 13(12) doi: 10.1080/17474124.2019.1697231
|
| 6 |
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2) doi: 10.14218/JCTH.2021.00268
|
| 7 |
Shankar Gharge, Shankar G. Alegaon, Rohini S. Kavalapure, Shriram D. Ranade, Nayeem.A. Khatib, B.R. Prashantha Kumar, Veeresh Prabhakar Veerapur, Ramith Ramu, Ashwini. P. Novel Imidazolidine-2,4-dione scaffolds: Rational design and biological evaluation for type-II diabetes management. Results in Chemistry 2026; 28 doi: 10.1016/j.rechem.2026.103524
|
| 8 |
Adel Hammoutene, Pierre-Emmanuel Rautou. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. Journal of Hepatology 2019; 70(6) doi: 10.1016/j.jhep.2019.02.012
|
| 9 |
Atsushi Sato, Yusuke Yumita, Kazuki Kagami, Yuki Ishinoda, Toyokazu Kimura, Ayumu Osaki, Takumi Toya, Takayuki Namba, Shogo Endo, Yasuo Ido, Yuji Nagatomo, Yasushi Satoh, Takeshi Adachi. Endothelial Extracellular Signal‐Regulated Kinase/Thromboxane A2/Prostanoid Receptor Pathway Aggravates Endothelial Dysfunction and Insulin Resistance in a Mouse Model of Metabolic Syndrome. Journal of the American Heart Association 2022; 11(23) doi: 10.1161/JAHA.122.027538
|
| 10 |
Iulia Minciuna, Madalina Gabriela Taru, Bogdan Procopet, Horia Stefanescu. The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Medicine 2024; 13(5) doi: 10.3390/jcm13051406
|
| 11 |
Yanling Zhang, Ying Zhang, Hongjin Chen, Fangfang Qi. Nitric oxide pathway: Emerging therapeutic strategies for MASLD. Pathology - Research and Practice 2026; 284 doi: 10.1016/j.prp.2026.156516
|
| 12 |
Miren Bravo, Imma Raurell, Diana Hide, Anabel Fernández-Iglesias, Mar Gil, Aurora Barberá, Maria Teresa Salcedo, Salvador Augustin, Joan Genescà, María Martell. Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56366-2
|
| 13 |
Olesia P. Balazh. ENDOTHELIUM DYSFUNCTION IN PATIENTS WITH LIVER CIRRHOSIS. Emergency Medical Service 2022; 9(3) doi: 10.36740/EmeMS202202105
|
| 14 |
Xue-Kai Wang, Zong-Gen Peng. Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655557
|
| 15 |
Eman M. EL-Shial, Amal Kabbash, Mona El-Aasr, Ola A. El-Feky, Suzy A. El-Sherbeni. Elucidation of Natural Components of Gardenia thunbergia Thunb. Leaves: Effect of Methanol Extract and Rutin on Non-Alcoholic Fatty Liver Disease. Molecules 2023; 28(2) doi: 10.3390/molecules28020879
|
| 16 |
Shriram D. Ranade, Shankar G. Alegaon, Nayeem A. Khatib, Shankar Gharge, Rohini S. Kavalapure, B.R. Prashantha Kumar. Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione's in fructose induced insulin resistant rats. European Journal of Medicinal Chemistry 2024; 280 doi: 10.1016/j.ejmech.2024.116939
|
| 17 |
M Gulubova, A Tolekova, D Berbatov, I Stefanov, D Chonov, N Aydoglu. Insulin- and glucagon-producing cells in the liver and biliary–pancreatic axis of rats with experimentally induced metabolic syndrome. Archives of Physiology and Biochemistry 2025; 131(5) doi: 10.1080/13813455.2025.2503482
|
| 18 |
Murali Ganesan, Larisa Y Poluektova, Kusum K Kharbanda, Natalia A Osna. Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression. World Journal of Gastroenterology 2019; 25(4): 398-410 doi: 10.3748/wjg.v25.i4.398
|
| 19 |
Eudith Januario, Aly Barakat, Abhivanditha Rajsundar, Zahra Fatima, Varda Nanda Palienkar, Arjun V Bullapur, Sunchandandeep Singh Brar, Punam Kharel, Mishal Mohammed Koyappathodi Machingal, Amena Backosh. A Comprehensive Review of Pathophysiological Link Between Non-alcoholic Fatty Liver Disease, Insulin Resistance, and Metabolic Syndrome. Cureus 2024; doi: 10.7759/cureus.75677
|
| 20 |
Niklas Verloh, Ingo Einspieler, Kirsten Utpatel, Karin Menhart, Stefan Brunner, Frank Hofheinz, Jörg van den Hoff, Philipp Wiggermann, Matthias Evert, Christian Stroszczynski, Dirk Hellwig, Jirka Grosse. In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT. EJNMMI Research 2018; 8(1) doi: 10.1186/s13550-018-0452-y
|
| 21 |
James Kim, Harpreet S. Bajaj, Alnoor Ramji, Chantal Bemeur, Giada Sebastiani. Diabetes and Metabolic Dysfunction–associated Steatotic Liver Disease in Adults: A Clinical Practice Guideline. Canadian Journal of Diabetes 2025; 49(4) doi: 10.1016/j.jcjd.2025.04.003
|
| 22 |
Olga Bondareva, Jesús Rafael Rodríguez-Aguilera, Fabiana Oliveira, Longsheng Liao, Alina Rose, Anubhuti Gupta, Kunal Singh, Florian Geier, Jenny Schuster, Jes-Niels Boeckel, Joerg M. Buescher, Shrey Kohli, Nora Klöting, Berend Isermann, Matthias Blüher, Bilal N. Sheikh. Single-cell profiling of vascular endothelial cells reveals progressive organ-specific vulnerabilities during obesity. Nature Metabolism 2022; 4(11) doi: 10.1038/s42255-022-00674-x
|
| 23 |
Bayan Abdulhafid Aljahdali, Adnan Salem Bajaber, Doha M. Al-Nouri, Abdulrahman Saleh Al-Khalifah, Shaista Arzoo, Abeer Abdullah Alasmari. The Development of Nonalcoholic Fatty Liver Disease and Metabolic Syndromes in Diet-Induced Rodent Models. Life 2023; 13(6) doi: 10.3390/life13061336
|
| 24 |
Manna Li, Ming Qian, Kathy Kyler, Jian Xu. Adipose Tissue-Endothelial Cell Interactions in Obesity-Induced Endothelial Dysfunction. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.681581
|
| 25 |
Marian A. Troelstra, Anne-Marieke Van Dijk, Julia J. Witjes, Anne Linde Mak, Diona Zwirs, Jurgen H. Runge, Joanne Verheij, Ulrich H. Beuers, Max Nieuwdorp, Adriaan G. Holleboom, Aart J. Nederveen, Oliver J. Gurney-Champion. Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.942495
|
| 26 |
Rostyslav Bubnov, Mykola Spivak. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16 doi: 10.1007/978-3-031-19564-8_6
|
| 27 |
Shuo Yuan, Hua-Min Zhang, Jia-Xin Li, You Li, Qi Wang, Guang-Yao Kong, Ao-Han Li, Ji-Xing Nan, Ying-Qing Chen, Qing-Gao Zhang. Gasotransmitters in non-alcoholic fatty liver disease: just the tip of the iceberg. European Journal of Pharmacology 2023; 954 doi: 10.1016/j.ejphar.2023.175834
|
| 28 |
Pierre-Emmanuel Rautou, Shivani Chotkoe, Louise Biquard, Guillaume Wettstein, Denise van der Graaff, Yao Liu, Joris De Man, Christophe Casteleyn, Sofie Thys, Winnok H. De Vos, Pierre Bedossa, Michael P. Cooreman, Martine Baudin, Jean-Louis Abitbol, Philippe Huot-Marchand, Lucile Dzen, Miguel Albuquerque, Pierre Broqua, Jean-Louis Junien, Luisa Vonghia, Manal F. Abdelmalek, Wilhelmus J. Kwanten, Valérie Paradis, Sven M. Francque. Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment. JHEP Reports 2025; 7(6) doi: 10.1016/j.jhepr.2025.101366
|
| 29 |
Mario Masarone, Valerio Rosato, Marcello Dallio, Antonietta Gerarda Gravina, Andrea Aglitti, Carmelina Loguercio, Alessandro Federico, Marcello Persico, Daniele Vergara. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/9547613
|
| 30 |
Agostino Di Ciaula, Federico Carbone, Harshitha Shanmugham, Emilio Molina-Molina, Leonilde Bonfrate, Stefano Ministrini, Fabrizio Montecucco, Piero Portincasa. Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver. European Journal of Internal Medicine 2021; 89 doi: 10.1016/j.ejim.2021.03.036
|
| 31 |
Emilio Molina-Molina, Harshitha Shanmugam, Agostino Di Ciaula, Ignazio Grattagliano, Domenica Maria Di Palo, Vincenzo O. Palmieri, Piero Portincasa. (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. JHEP Reports 2021; 3(1) doi: 10.1016/j.jhepr.2020.100203
|
| 32 |
Narjes Nasiri-Ansari, Theodoros Androutsakos, Christina-Maria Flessa, Ioannis Kyrou, Gerasimos Siasos, Harpal S. Randeva, Eva Kassi, Athanasios G. Papavassiliou. Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review. Cells 2022; 11(16) doi: 10.3390/cells11162511
|
| 33 |
Luz M. Medrano, Pilar Garcia-Broncano, Juan Berenguer, Juan González-García, Ma Ángeles Jiménez-Sousa, Josep M. Guardiola, Manuel Crespo, Carmen Quereda, José Sanz, Isabel Canorea, Ana Carrero, Victor Hontañón, Ma Ángeles Muñoz-Fernández, Salvador Resino. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients. AIDS 2018; 32(9) doi: 10.1097/QAD.0000000000001787
|
| 34 |
Nihat Aydın, Mustafa Capraz, Burcu Akman, Seyma Nur Altınok, Melek Tufek, Caner Kara. Does metabolic dysfunction-associated steatotic liver disease affect the ocular circulation?. Photodiagnosis and Photodynamic Therapy 2026; 57 doi: 10.1016/j.pdpdt.2026.105334
|